John Leung

John Leung


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2015 in Ophthalmology
Verified
Journal Article
Closed access
AWAndre J. Witkin
Andre J. Witkin
ASAnjali R. Shah
Anjali R. Shah
RERobert E. Engstrom
Robert E. Engstrom
MKMichelle M. Kron-Gray
Michelle M. Kron-Gray
CBCaroline R. Baumal
Caroline R. Baumal
DEDean Eliott
Dean Eliott

1 November 2021 in Clinical Gastroenterology and Hepatology
Verified
Journal Article
Open access
FOFrances Onyimba
Frances Onyimba
SCSheila E. Crowe
Sheila E. Crowe
SJSarah Johnson
Sarah Johnson
JLJohn Leung
John Leung
Food allergy is an aberrant immunological response to food antigen, which can result in potentially life-threatening reactions. It is often challenging to differentiate food allergy from other adverse reactions to food because their presentations can be indistinguishable. The purpose of this article is to give an overview of the classification, evaluation, and management of adverse food reactions, key differentiating features of food allergy, roles and limitations of various food allergy testing, and promising areas of emerging research. Case studies are used to highlight some of the clinical pearls in diagnosing and managing food-related diseases.

27 September 2023 in Clinical and Translational Gastroenterology
Verified
Journal Article
Open access
TSTwan Sia
Twan Sia
LBLeeon Bacchus
Leeon Bacchus
RTRiki Tanaka
Riki Tanaka
RKRaisa Khuda
Raisa Khuda
SMShibani Mallik
Shibani Mallik
JLJohn Leung
John Leung
INTRODUCTION: Noneosinophilic esophagitis eosinophilic gastrointestinal disorders (non–EoE-EGIDs) have limited treatment options to induce histologic and clinical remission. Dupilumab is a human monoclonal antibody against the interleukin-4 receptor ɑ subunit, which has been reported to induce improvement in pediatric patients with non–EoE-EGIDs. METHODS: We conducted a retrospective chart review to identify if patients with eosinophilic gastritis (EoG) and/or eosinophilic duodenitis (EoD) experience clinical and histologic remission with dupilumab. RESULTS: Twelve patients were included (2 patients with EoG and EoD, 3 patients with EoG only, and 7 patients with EoD only). All patients experienced improvement of at least 1 symptom on dupilumab, 3 patients (25%) had no change in severity of 1 or more of their symptoms, and no patients had worsening symptoms. On dupilumab, 2 patients with EoG (40%) and 3 patients with EoD (33.3%) were completely asymptomatic. Histologic changes were investigated in a subanalysis including 8 patients (2 patients with EoG and EoD, 2 patients with EoG only, and 4 patients with EoD only). Median peak gastric eosinophil counts in patients with EoG reduced from 80.5 eos/hpf (min–max 32–150, Q1–Q3 45.5–111) to 7.5 eos/hpf (min–max 0–28, Q1–Q3 1.5–16.8). Median peak duodenal eosinophil counts in patients with EoD reduced from 39 eos/hpf (min–max 30–50, Q1–Q3 37.3–46.3) to 16.5 eos/hpf (min–max 0–50, Q1–Q3 8–38.5). All 4 patients (100%) with EoG and 4 patients (66.6%) with EoD had histologic remission on dupilumab. DISCUSSION: In this retrospective case series, we showed preliminary evidence that dupilumab may be effective in inducing histologic and symptomatic remission in patients with non–EoE-EGIDs.

1 April 2016 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
KKKara L. Kliewer
Kara L. Kliewer
CVCarina Venter
Carina Venter
ACAlison M. Cassin
Alison M. Cassin
JAJ. Pablo Abonia
J. Pablo Abonia
SASeema S. Aceves
Seema S. Aceves
MRMarc E. Rothenberg
Marc E. Rothenberg

1 October 2015 in Best Practice & Research Clinical Gastroenterology
Verified
Journal Article
Closed access
JLJohn Leung
John Leung
KBKoen Robert Beukema
Koen Robert Beukema
ASAlice Hangzhou Shen
Alice Hangzhou Shen

18 February 2010 in Digestive Diseases and Sciences
Verified
Journal Article
Closed access
PDF file
JLJohn Leung
John Leung
LDLauren Dowling
Lauren Dowling
IOIsi Obadan
Isi Obadan
JDJames Davis
James Davis
PBPeter A. Bonis
Peter A. Bonis
KVKathleen Viveiros
Kathleen Viveiros